The parapharmacy market - Italy

The parapharmacy market includes the sale of pharmaceutical and extra-pharmaceutical products, such as over-the-counter drugs, dietary supplements, medical devices, and cosmetics, intended to improve people's health and well-being. In recent years, this sector has been booming, with an estimated size of $1,224.73 billion in 2023 and a projected compound annual growth rate (CAGR) of 6.6 percent. Market growth is being driven by demographic and health factors, such as anaging population, which requires a greater supply of products for health management and disease prevention, and the rise of chronic diseases, which stimulate the consumption of supplements and supportive devices. In addition, the spread of accessible and convenient outlets, including online platforms, has further boosted demand. In Europe, the non-prescription drug (SOP) market accounted for 19.0 percent of the entire pharmaceutical market in 2023, with a value of more than 46 billion euros in the 17 countries analyzed. However, in Italy, per capita spending on SOP drugs remains below the European average, indicating a still untapped growth potential. The Italian parapharmacy sector is characterized by a widespread network of pharmacies and parapharmacies, with one pharmacy for every 3,500-5,000 inhabitants, providing an essential service throughout the country. The Italian parapharmacy market, with an estimated value of about 850 million euros per year, employs more than 8,200 people and is developed in medium-sized facilities, with premises of 70.5 square meters and warehouses of 50.5 square meters. The presence of storefronts on the street, found in 70 percent of cases, and the continuous opening of new outlets (more than 100 each year) testify to the vitality of a sector that continues to evolve to meet the needs of the population and new consumer dynamics, including the growing preference for e-commerce.